Jonathan Nazari

6PUBLICATIONS
11CO-AUTHORS
Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Digital and electronic media artPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 10, 2025
Frequency and severity response scales for pain and discomfort: psychometric insights from EQ-HWB.

Soumana C Nasser, A Simon Pickard, Jonathan L Nazari

|Mar 06, 2025
Matching-adjusted indirect comparison of talazoparib plus enzalutamide versus abiraterone acetate and docetaxel in mCRPC.

Elena Castro, Di Wang, Sarah Walsh

|Nov 26, 2024
Systematic literature review and meta-analysis of health state utility values in metastatic castration-resistant prostate cancer.

Elena Castro, Rhett Figliuzzi, Sarah Walsh

|Oct 19, 2024
Comparative efficacy and safety of talazoparib plus enzalutamide and other first-line treatments for metastatic castration-resistant prostate cancer.

Elena Castro, Jenna Ellis, Samantha Craigie

|Apr 23, 2024
Implementation of virtual academic detailing in North America: A qualitative study.

Jonathan L Nazari, Victoria Kulbokas, Mary H Smart

|Aug 17, 2023
The impact of race on survival in metastatic prostate cancer: a systematic literature review.

Stephen J Freedland, Imtiaz A Samjoo, Emily Rosta

Pageof 1

Frequent Collaborators

3 joint publications

Elena Castro

3 joint publications

Imtiaz A Samjoo

2 joint publications

Anja Haltner

1 joint publications

Mary H Smart